Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

NCT01140126 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection in Adults (Asymptomatic)

Interventions

DRUG: Antibody UB-421

Sponsor

United Biomedical